Stay updated on CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial
Sign up to get notified when there's something new on the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page.

Latest updates to the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new version of the CLN-049 trial record was posted on October 28, 2026, with updates across study identification, oversight, description, design, conditions, interventions, outcome measures, eligibility, and contacts/locations.SummaryDifference1%

- Check16 days agoChange DetectedA banner announces NIH website transition updates and says federal agencies are adopting “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with both terms appearing during the transition.SummaryDifference0.7%

- Check23 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check30 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check44 days agoChange DetectedMultiple revisions to the trial's status and contact/location details are shown across versions. These updates reflect ongoing maintenance of the study record as it evolves over time.SummaryDifference0.1%

- Check51 days agoChange DetectedThe capitalization of the label was updated from 'Find Contact Information' to 'Find contact information', and the revision entries show 'Revision: v3.7.0' being added while 'Revision: v3.6.6' is removed, reflecting a small update to the history section.SummaryDifference0.2%

Stay in the know with updates to CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page.